200 related articles for article (PubMed ID: 1656049)
1. X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants.
Eigenbrot C; Randal M; Quan C; Burnier J; O'Connell L; Rinderknecht E; Kossiakoff AA
J Mol Biol; 1991 Sep; 221(1):15-21. PubMed ID: 1656049
[TBL] [Abstract][Full Text] [Related]
2. Introduction of relaxin properties into other hormones of insulin-like structure.
Büllesbach EE; Schwabe C
SAAS Bull Biochem Biotechnol; 1996; 9():63-8. PubMed ID: 8652134
[TBL] [Abstract][Full Text] [Related]
3. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
4. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
5. Identification of the receptor-recognition surface of bombyxin-II, an insulin-like peptide of the silkmoth Bombyx mori: critical importance of the B-chain central part.
Nagata K; Hatanaka H; Kohda D; Kataoka H; Nagasawa H; Isogai A; Ishizaki H; Suzuki A; Inagaki F
J Mol Biol; 1995 Nov; 253(5):759-70. PubMed ID: 7473750
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of allosteric ligand-receptor interactions in the insulin/relaxin peptide family: implications for other receptor tyrosine kinases and G-protein-coupled receptors.
De Meyts P; Gauguin L; Svendsen AM; Sarhan M; Knudsen L; Nøhr J; Kiselyov VV
Ann N Y Acad Sci; 2009 Apr; 1160():45-53. PubMed ID: 19416158
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional solution structure of bombyxin-II an insulin-like peptide of the silkmoth Bombyx mori: structural comparison with insulin and relaxin.
Nagata K; Hatanaka H; Kohda D; Kataoka H; Nagasawa H; Isogai A; Ishizaki H; Suzuki A; Inagaki F
J Mol Biol; 1995 Nov; 253(5):749-58. PubMed ID: 7473749
[TBL] [Abstract][Full Text] [Related]
8. Structure and activity in the relaxin family of peptides.
Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
[TBL] [Abstract][Full Text] [Related]
9. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor.
Ward CW; Lawrence MC
Bioessays; 2009 Apr; 31(4):422-34. PubMed ID: 19274663
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into the function of relaxins.
Rosengren KJ; Bathgate RA; Craik DJ; Daly NL; Haugaard-Jönsson LM; Hossain MA; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():20-6. PubMed ID: 19416153
[TBL] [Abstract][Full Text] [Related]
11. Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1.
Svendsen AM; Zalesko A; Kønig J; Vrecl M; Heding A; Kristensen JB; Wade JD; Bathgate RA; De Meyts P; Nøhr J
Mol Cell Endocrinol; 2008 Dec; 296(1-2):10-7. PubMed ID: 18723073
[TBL] [Abstract][Full Text] [Related]
12. Synthetic human insulin 4 does not activate the G-protein-coupled receptors LGR7 or LGR8.
Lin F; Otvos L; Kumagai J; Tregear GW; Bathgate RA; Wade JD
J Pept Sci; 2004 May; 10(5):257-64. PubMed ID: 15160837
[TBL] [Abstract][Full Text] [Related]
13. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
14. Comparison of relaxin receptors in rat isolated atria and uterus by use of synthetic and native relaxin analogues.
Tan YY; Wade JD; Tregear GW; Summers RJ
Br J Pharmacol; 1998 Feb; 123(4):762-70. PubMed ID: 9517397
[TBL] [Abstract][Full Text] [Related]
15. Mouse relaxin: synthesis and biological activity of the first relaxin with an unusual crosslinking pattern.
Büllesbach EE; Schwabe C
Biochem Biophys Res Commun; 1993 Oct; 196(1):311-9. PubMed ID: 8216305
[TBL] [Abstract][Full Text] [Related]
16. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
[TBL] [Abstract][Full Text] [Related]
17. Modeling the primary hormone-binding site of RXFP1 and RXFP2.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162
[TBL] [Abstract][Full Text] [Related]
18. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
19. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
20. The expression of human relaxin in yeast.
Yang S; Heyn H; Zhang YZ; Büllesbach EE; Schwabe C
Arch Biochem Biophys; 1993 Feb; 300(2):734-7. PubMed ID: 8382033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
